相似文献
1
HIV-1 hides an Achilles' heel in virion lipids.
Immunity. 2008 Jan;28(1):10-2. doi: 10.1016/j.immuni.2007.12.005.
2
Characterization of the multiple conformational States of free monomeric and trimeric human immunodeficiency virus envelope glycoproteins after fixation by cross-linker.
J Virol. 2006 Jul;80(14):6725-37. doi: 10.1128/JVI.00118-06.
3
Antigenic properties of the HIV envelope on virions in solution.
J Virol. 2014 Feb;88(3):1795-808. doi: 10.1128/JVI.03048-13. Epub 2013 Nov 27.
4
Inducible cell lines producing replication-defective human immunodeficiency virus particles containing envelope glycoproteins stabilized in a pretriggered conformation.
J Virol. 2024 Dec 17;98(12):e0172024. doi: 10.1128/jvi.01720-24. Epub 2024 Nov 7.
5
Short Communication: Virion Aggregation by Neutralizing and Nonneutralizing Antibodies to the HIV-1 Envelope Glycoprotein.
AIDS Res Hum Retroviruses. 2015 Nov;31(11):1160-5. doi: 10.1089/AID.2015.0050. Epub 2015 Jul 20.
6
Broadly neutralizing antibody epitopes on HIV-1 particles are exposed after virus interaction with host cells.
J Virol. 2023 Sep 28;97(9):e0071023. doi: 10.1128/jvi.00710-23. Epub 2023 Sep 8.
7
Multifaceted consequences of anti-gp41 monoclonal antibody 2F5 binding to HIV type 1 virions.
AIDS Res Hum Retroviruses. 1995 Jun;11(6):687-96. doi: 10.1089/aid.1995.11.687.
8
The role of antibody polyspecificity and lipid reactivity in binding of broadly neutralizing anti-HIV-1 envelope human monoclonal antibodies 2F5 and 4E10 to glycoprotein 41 membrane proximal envelope epitopes.
J Immunol. 2007 Apr 1;178(7):4424-35. doi: 10.4049/jimmunol.178.7.4424.
9
Discrete partitioning of HIV-1 Env forms revealed by viral capture.
Retrovirology. 2015 Sep 24;12:81. doi: 10.1186/s12977-015-0207-z.
10
Induction of neutralizing antibodies against human immunodeficiency virus type 1 primary isolates by Gag-Env pseudovirion immunization.
J Virol. 2005 Dec;79(23):14804-14. doi: 10.1128/JVI.79.23.14804-14814.2005.
引用本文的文献
1
Progress with induction of HIV broadly neutralizing antibodies in the Duke Consortia for HIV/AIDS Vaccine Development.
Curr Opin HIV AIDS. 2023 Nov 1;18(6):300-308. doi: 10.1097/COH.0000000000000820. Epub 2023 Sep 25.
2
Progress in HIV-1 vaccine development.
J Allergy Clin Immunol. 2014 Jul;134(1):3-10; quiz 11. doi: 10.1016/j.jaci.2014.04.025. Epub 2014 Jun 26.
3
Chemically modified peptides based on the membrane-proximal external region of the HIV-1 envelope induce high-titer, epitope-specific nonneutralizing antibodies in rabbits.
Clin Vaccine Immunol. 2014 Aug;21(8):1086-93. doi: 10.1128/CVI.00320-14. Epub 2014 May 28.
4
Rational design of membrane proximal external region lipopeptides containing chemical modifications for HIV-1 vaccination.
Clin Vaccine Immunol. 2013 Jan;20(1):39-45. doi: 10.1128/CVI.00615-12. Epub 2012 Oct 31.
5
GB virus C: the good boy virus?
Trends Microbiol. 2012 Mar;20(3):124-30. doi: 10.1016/j.tim.2012.01.004. Epub 2012 Feb 8.
6
High level of soluble HLA-G in the female genital tract of Beninese commercial sex workers is associated with HIV-1 infection.
PLoS One. 2011;6(9):e25185. doi: 10.1371/journal.pone.0025185. Epub 2011 Sep 23.
7
Envelope deglycosylation enhances antigenicity of HIV-1 gp41 epitopes for both broad neutralizing antibodies and their unmutated ancestor antibodies.
PLoS Pathog. 2011 Sep;7(9):e1002200. doi: 10.1371/journal.ppat.1002200. Epub 2011 Sep 1.
8
Topology of the C-terminal tail of HIV-1 gp41: differential exposure of the Kennedy epitope on cell and viral membranes.
PLoS One. 2010 Dec 7;5(12):e15261. doi: 10.1371/journal.pone.0015261.
9
Crystal structure of a non-neutralizing antibody to the HIV-1 gp41 membrane-proximal external region.
Nat Struct Mol Biol. 2010 Dec;17(12):1492-4. doi: 10.1038/nsmb.1944. Epub 2010 Nov 14.
10
GB virus type C envelope protein E2 elicits antibodies that react with a cellular antigen on HIV-1 particles and neutralize diverse HIV-1 isolates.
J Immunol. 2010 Oct 1;185(7):4496-505. doi: 10.4049/jimmunol.1001980. Epub 2010 Sep 8.
本文引用的文献
1
HIV-1 broadly neutralizing antibody extracts its epitope from a kinked gp41 ectodomain region on the viral membrane.
Immunity. 2008 Jan;28(1):52-63. doi: 10.1016/j.immuni.2007.11.018.
2
The role of antibody polyspecificity and lipid reactivity in binding of broadly neutralizing anti-HIV-1 envelope human monoclonal antibodies 2F5 and 4E10 to glycoprotein 41 membrane proximal envelope epitopes.
J Immunol. 2007 Apr 1;178(7):4424-35. doi: 10.4049/jimmunol.178.7.4424.
3
An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10.
J Virol. 2007 Apr;81(8):4033-43. doi: 10.1128/JVI.02588-06. Epub 2007 Feb 7.
4
Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates.
Expert Rev Vaccines. 2006 Aug;5(4):579-95. doi: 10.1586/14760584.5.4.579.
5
Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies.
Science. 2005 Jun 24;308(5730):1906-8. doi: 10.1126/science.1111781. Epub 2005 Apr 28.
6
Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41.
Immunity. 2005 Feb;22(2):163-73. doi: 10.1016/j.immuni.2004.12.011.
7
Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope.
J Virol. 2004 Oct;78(19):10724-37. doi: 10.1128/JVI.78.19.10724-10737.2004.
8
Immunoglobulin heavy chain expression shapes the B cell receptor repertoire in human B cell development.
J Clin Invest. 2001 Sep;108(6):879-86. doi: 10.1172/JCI13051.
9
Mechanisms of viral membrane fusion and its inhibition.
Annu Rev Biochem. 2001;70:777-810. doi: 10.1146/annurev.biochem.70.1.777.
10
Atomic structure of the ectodomain from HIV-1 gp41.
Nature. 1997 May 22;387(6631):426-30. doi: 10.1038/387426a0.
Zotero 插件